Physiotherapy in the Integrated Approach to Management of Deviated Gait Patterns in Cerebral Palsy

1. Cans C. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy
surveys and registers. Dev Med Child Neurol. 2000;42:816-24.
2. Stevens S. Definition and classification of cerebral palsy. Dev Med Child Neurol.
2005;47:509-10.
3. McConachie H, Colver AF, Forsyth RJ, Jarvis SN, Parkinson K. Participation of
disabled children: how it should be characterized and measured? Disability and Rehabilitation 2006; 28(18):1157-64.
4. Nawotny J. Current aspects of rehabilitation of children with Cerebral Palsy. Reh
med. 2003;7(3):64-9.
5. Scholtes VA, Dallmeijer AJ, Knol DL, Speth LA, Maathuis CG, Jongerius PH,
Becher JG. Effect of multilevel botulinum toxin A and comprehensive rehabilitation
on gait in cerebral palsy. Pediatr Neurol 2007;36:30-39.
6. Novacheck T,Gage JR. Orthopedic management of spasticity in cerebral palsy.
Childs Nerv Syst. 2007;23:1015–1031.
7.Gage J. Gait analysis in Cerebral Palsy. Mac Keith Press. 1991; pp101.
8. Scivoletto G, Romanelli A, Mariotti A, Marinucci D, Tamburella F, Mammone
A, Cosentino E, Sterzi S, Molinari M. Clinical Factors That Affect Walking Level
and Performance in Chronic Spinal Cord Lesion Patients. Spine.2008;33(3):259-
264.
9. Waters RL, Mulroy S. The energy expenditure of normal and pathologic gait.
Gait and Posture. 1999;9:207–31.
10. Wren TA, Rethlefsen S, Kay RM. Prevalence of specific gait abnormalities in
children with cerebral palsy: Influence of cerebral palsy subtype, age, and previous
surgery. J Pediatr Orthop 2005;25:79-83
11. Berker AN, Yalcin MS.Cerebral Palsy: Orthopedic aspects and rehabilitation.
Pediatr Clin North Am. 2008,55(5):1209-25.
12. Hartley J. Physiotherapy in the management of cerebral palsy. Hospl Med.
2002;63(10):590-92
13. Dodge NN. Cerebral Palsy:Medical Aspects. Pediatr Clin North Am.
2008;55(5):1189-1207.
14. Siebes RC, Wijnroks L, Vermeer A. Qualitative analysis of therapeutic motor
intervention programmes for children with cerebral palsy: an update. Dev Med
Child Neurol. 2002;44:593-603.
15. Brown GT, Burns SA. The efficacy of neurodevelopmental treatments in children: a systematic review. Br J Occup Ther. 2001;64:235-244.
16. DeGangi GA, Royeen CB. Current practice among NeuroDevelopmental Treatment Association members. Am J Occup Ther. 1994 Sep;48(9):803-9.
17. Dursun, E, Dursun, N, Duygu A. Effects of biofeedback treatment on gait in
children with cerebral palsy,Disability & Rehabilitation. 2004;26:2,116-120.
18. Jeanson E. Neurodevelopmental Therapy. In: Freeman Miller. Physical Therapy
of Cerebral Palsy. New York: Springer Science, 2007;345-6.
19. Butler C, Darrah J. AACPDM Evidence report: Effects of neurodevelopmental
treatment (NDT) for cerebral palsy. Dev Med Child Neurol. 2001;43:778-90.
20. Tsorlakis N, Evaggelinou C, Grouios G, Tsorbatzoudis C. Effect of intensive
neurodevelopmental treatment in gross motor function of children with cerebral
palsy. Dev Med Child Neurol. 2004;46:740-45.
21. Knox V., Evans AL. Evaluation of the functional effects of a course of Bobath
therapy in children with cerebral palsy: a preliminary study. Dev Med Child Neurol. 2002;44: 447–60.
22. Arndt SW, Chandler LS, Sweeney JK, Sharkey MA, McElroy JJ. Effects of a
neurodevelopmental treatment-based trunk protocol for infants with posture and
movement dysfunction. Pediatr Phys Ther. 2008;20(1):11-22.
23. Wiley M, Damiano D. Lower-Extremity Strength Profiles in Spastic Cerebral
Palsy. Dev Med Child Neurol. 1998;40:100–107.
24. Damiano D. Strengthening exercises. In: Freeman Miller. Physical Therapy of
Cerebral Palsy. New York: Springer Science, 2007:346-8.
25. Dodd K, Taylor N, Damiano D. A systematic review of the effectiveness of
strength-training programs for people with cerebral palsy. Arch Phys Med Rehabil.
2002;83:1157-64.
26. Eek Nyström M, Tranberg R, Zügner R, Alkema K, Beckung E. Muscle
strength training to improve gait function in children with cerebral palsy. Dev
Med Child Neurol. Oct 2008;50(10):759-64.
27.Tardieu G, Tardieu P, Colbeau-Justin P, Lespargot A. Muscle hypoextensibility
in children with cerebral palsy : II. Therapeutic implications. Arch Phys Med Rehabil 1982:63;103-7.
28. Brouwer B, Wheeldon RK, Stradiotto-Parker N, Allum J. Reflex excitability
and isometric force production in cerebral palsy: the effect of serial casting. Dev
Med Child Neurol 1998:40;168-75.
29. Teplicky R, Law M, Russell D. The effectiveness of casts, orthoses, and splints
for children with neurological disorders. Infants Young Child. 2002;15:42-50.
30. Glanzman A, Kim H, Swaminathan K, Beck T. Efficacy of botulinum toxin A,
serial casting, and combined treatment for spastic equinus: a retrospective analysis.
Dev Med Child Neurol. 2004;46:807-11.
31. Münchau A, Bhatia K P. Uses of botulinum toxin injection in medicine today.
BMJ. 2000;320:161-5.
32. Ward A. The use of botulinum toxin type A in spastic diplegia due to cerebral
palsy. European Journal of Neurology. 1999;6(Suppl 4):S95-8.
33. Wissel J, Muller J, Baldauf A, Ung S, Ndayis JP. Gait analysis to assess the effects of botulinum toxin type A treatment in cerebral palsy: an open-label study in
10 children with equinus gait pattern. European Journal of Neurology.
1999;6(suppl 4):S63-7.
34. Goldstein M, Harper D. Management of cerebral palsy: Equinus gait. Dev Med
Child Neurol. 2001;43(8):563-9.
35. Molenaers G, Desloovere K, Eyssen M, Decaf J, Jonkers I, De Cock P. Botulinum toxin type A treatment of cerebral palsy: an integrated approach. European
Journal of Neurology. 1999;6(suppl 4):S51-7